Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACR in MS patients treated with Gilenya
NCT02141022Completed
- Sponsor
- Stony Brook University
- Start
- Aug 2013
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Stony Brook University. Primary endpoint: Change from Baseline in Neuropsychological Test Results at 12 weeks. Started Aug 2013; status: completed.
Beyond the preview
Go deeper on NCT02141022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141022.